SCHEMBL30809339

SCHEMBL30809339

O=C1Nc2cc(Cl)ncc2C1(Br)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1233666 1.00
SCHEMBL13733446 0.79 PGR (0.44)
SCHEMBL16324025 0.77 PGR (0.43)
SCHEMBL30809082 0.77 PGR (0.43)
SCHEMBL1232197 0.75 PGR (0.46)
SCHEMBL30809074 0.75 PGR (0.46)
SCHEMBL30809204 0.75 PGR (0.46)
SCHEMBL30809228 0.72 GSK3B (0.36)
SCHEMBL23671540 0.71 MAPK14 (0.45)
SCHEMBL5485978 0.70 CHRM2 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543544-A1 TYROSINE KINASE 2 INHIBITORS AND USES THEREOF Biogen MA Inc. (US) 2025-04-30 EP disclosed
CN-119866338-A Tyrosine kinase 2 inhibitors and uses thereof 渤健马萨诸塞州股份有限公司 2025-04-22 CN disclosed
WO-2023250064-A1 TYROSINE KINASE 2 INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-12-28 WO disclosed